The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
01 Jan 2019
Historique:
received: 05 06 2018
accepted: 10 07 2018
pubmed: 31 8 2018
medline: 15 3 2019
entrez: 31 8 2018
Statut: ppublish

Résumé

In many jurisdictions, public safety and public health entities are working together to enhance the timeliness and accuracy of the analytical characterization and toxicology testing of novel synthetic opioids. The improved sharing and early detection of these analytical data are intended to inform surveillance, interdiction efforts, patient intervention and treatment, all of which are critical to curbing the opioid epidemic. Forensic practitioners working to identify novel synthetic opioids struggle to provide timely results when encountering new or unknown substances, such as the fentanyl analogs. These compounds, which mimic heroin in pharmacologic effect but can be far more potent, are inconsistently present in chemical identification libraries, and are currently largely unavailable as reference materials for analytical comparison. Additionally, federal, state and local governments as well as nongovernmental organizations require potency, toxicity and potential-for-abuse data to evaluate the potential health risks of emerging drug threats. Subsequent scheduling efforts and criminal prosecutions also require these thorough drug characterization studies. Pilot programs have demonstrated that early communication of real-time drug toxicity and analytical data significantly impacts the successful response to emerging opioids. High-quality, real-time, national-level data on chemical composition, toxicological test data, drug toxicity and overdoses, and analysis of seized materials by law enforcement are needed to track drug trends. However, the USA still lacks a national system to coordinate and communicate toxicology, medical and medical examiner and coroner data with the broader medical and law enforcement communities. Opportunities to address these gaps as well as recent advancements collected through interagency efforts and technical workshops in the toxicology and analytical chemistry communities are presented here. Opportunities for partnership, increased communication and expanding best practices to move toward an integrated, holistic analytical response are also explored.

Identifiants

pubmed: 30165647
pii: 5079801
doi: 10.1093/jat/bky049
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Auteurs

Jayne B Morrow (JB)

Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA.

Jeri D Ropero-Miller (JD)

RTI International, Research Triangle Park, NC, USA.

Megan L Catlin (ML)

National Heroin Coordination Group, Office of National Drug Control Policy, Washington, DC, USA.

Agnes D Winokur (AD)

Office of Forensic Sciences for the Drug Enforcement Administration's (DEA) Southeast Laboratory, Miami, FL, USA.

Amy B Cadwallader (AB)

Council on Science and Public Health, American Medical Association, Chicago, IL, USA.

Jessica L Staymates (JL)

Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA.

Shannan R Williams (SR)

Office of Special Programs, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA.

Jonathan G McGrath (JG)

DOJ National Institute of Justice, Office of Investigative and Forensic Sciences, Washington, DC, USA.

Barry K Logan (BK)

NMS Labs, Willow Grove, PA, USA.

Michael M McCormick (MM)

US Customs and Border Protection, Washington, DC, USA.

Kurt B Nolte (KB)

Pathology and Radiology, New Mexico Office of the Medical Investigator, Albuquerque, NM, USA.

Thomas P Gilson (TP)

Cuyahoga County Regional Forensic Sciences Laboratory, Cleveland, OH, USA.

M J Menendez (MJ)

Organized Crime Drug Enforcement Task Forces, Department of Justice, Washington, DC, USA.

Bruce A Goldberger (BA)

University of Florida, Gainesville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH